Evidence map›Paper›PMID 28331611›Full record

ArticleJournal of therapeutic ultrasound2017

Long-term efficacy of ultrasound-guided high-intensity focused ultrasound treatment of breast fibroadenoma.

Roussanka Kovatcheva, Katja Zaletel, Jordan Vlahov, Julian Stoinov

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of therapeutic ultrasound, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01331954 (Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01331954 naunknown statusnot on this map

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU): a Feasibility Study

TypeinterventionalSponsorTheraclionRan2011 to 2024Enrolled20ConditionsBreast FibroadenomaArmsUltrasonic ablation device
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Roussanka KovatchevaDepartment of Thyroid and Metabolic Bone Disorders, University Hospital of Endocrinology, Medical University of Sofia, 2, Zdrave Street, 1431 Sofia, Bulgaria.ORCID 0000-0003-1894-8433
Katja ZaletelDepartment of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Jordan VlahovDepartment of Thyroid and Metabolic Bone Disorders, University Hospital of Endocrinology, Medical University of Sofia, 2, Zdrave Street, 1431 Sofia, Bulgaria.
Julian StoinovDepartment of Endocrine Surgery, University Hospital of Endocrinology, Medical University of Sofia, Sofia, Bulgaria.
Medical University of Sofia · BGLjubljana University Medical Centre · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo assess the long term efficacy and tolerability of one or two ultrasound (US)-guided high-intensity focused ultrasound (HIFU) treatment in patients with breast fibroadenoma (FA).

methodsTwenty patients with 26 FA were selected for US-guided HIFU. The therapy was performed in one or two sessions. FA volume was assessed before and followed up to 24 months after the last HIFU. After each treatment, adverse events were evaluated.

resultsIn 19/26 FA (73.1%) one HIFU was performed (group 1), whereas 7/26 FA (26.9%) received second HIFU (group 2) 6-9 months (median, 7 months) after the first session. In group 1 and 2, FA volume decreased significantly at 1-month (

conclusionsUS-guided HIFU represents a promising non-invasive method with sustainable FA volume reduction and patient's tolerability. Although one treatment is highly efficient, the volume reduction can be increased with second treatment.

trial registrationNCT01331954. Registered 07 April 2011.

Indexed as

Ablation techniquesBreast fibroadenomaHigh-intensity focused ultrasound (HIFU)Interventional ultrasonographyUltrasound (US) guidance

Identifiers

PMID28331611
PMCPMC5353785
OpenAlexW2571664318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.